Regulatory inspections in 2026 are becoming increasingly risk-based, data-driven, and globally connected. Life sciences organizations must be prepared to demonstrate control across their quality systems, digital technologies, data integrity practices, supplier networks, facilities, and day-to-day operations.
This comprehensive whitepaper examines evolving FDA, EMA, and global inspection expectations while providing practical strategies for building continuous inspection readiness. Learn how to strengthen your readiness program, prepare personnel, conduct effective mock inspections, manage regulatory requests, and respond to findings with confidence.
To learn more about EMMA International’s regulatory affairs, global market access, and compliance consulting services, click here.
Download EMMA International Whitepapers
Complete the form below to receive selected EMMA International whitepapers directly to your inbox.
